Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.

In 2009, Invacare initiated a strategic plan that is focused on “glocalisation”, in which it will manage its business globally yet be flexible enough to meet local market needs. Some time ago, the company recognised that its product portfolio of highly-tailored regional products would not be cost-effective in a world of declining reimbursement. For example, French products were designed, engineered and sold primarily in France. That same business model was applied in each of the company’s regional businesses worldwide, leading to duplication in products and engineering, as well as inefficiencies in sourcing. Glocalisation will serve as a key driver of future growth and lower costs by simplifying the company’s product lines and eliminating unnecessary complexity. Through this initiative, Invacare has begun to leverage its global purchasing power, research and development (R&D), engineering, systems and other support functions. As Invacare globalises, the company says it will eliminate redundant activities, increase agility, drive innovation, deliver profitable growth and reduce complexities both internally and externally for its customers. Glocalisation is expected to achieve annualised savings of US$100 million over a five-year period, which will drive gross margin expansion, allow for increased investment in R&D and help offset pricing/reimbursement pressures over time. In 2010, Invacare also established a new organisational structure that will allow senior management to accelerate the implantation of its global initiatives.

As Invacare looks to return to organic sales growth (+7% in 2008, -0.2% in 2009 and 1% in 2010), the company will pursue opportunities to:

Expand its core business – Over the five years beginning in 2010, Invacare aims to double R&D spending for new product development funded by its savings from glocalisation. The company will focus on innovation, which the company believes has been a key ingredient to its success, and maximise market share opportunities within existing geographies.
Explore new business opportunities beyond Invacare’s traditional product platforms, including therapeutic support surfaces and negative pressure wound therapy.
Increase its presence in new markets, such as Latin America, China and Eastern Europe.

The report was produced as part of Medical Device Companies Analysis (MDCA). For more information on MDCA, click here.

This company report provides

Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format

Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location

Strategic Focus
Investigates the company’s aims and its areas of focus

Products
Core product areas, key brands, product approvals and launches Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?

Manufacturing and Distribution
Identifying the company’s manufacturing locations
Sales and marketing facilities

Agreements
With whom has the company reached agreements and what do they involve?
Key contracts awarded

Mergers, Acquisitions, Minority Investments and Divestments

Litigation

Key Corporate Events

Pharmaceutical Market Research

Invacare Medical Device Company Intelligence Report

Invacare Medical Device Company Intelligence Report

Contents

Related products